SILO · Silo Pharma, Inc. · Exempt Offerings
$1.49
+0.03 (+2.19%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 13, 2026
The latest filing states the doubt was alleviated.
“The positive working capital and the July 2026 Private Placement (see Note 9) serve to mitigate the conditions that historically raised substantial doubt about the Company’s ability to continue as a going concern. The Company believes that it has sufficient cash and liquid short-term investments to meet its obligations for a minimum of twelve months from the date of this filing.”View the 10-Q filed Aug 13, 2026
Market Cap
$2.78M
Shares
1.59M
Volume · Oct 5
212.18K
Avg daily vol (3M)
208.53K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-07-14 | New | Pharmaceuticals | $4,000,015 | $4,000,015 | 06b |
| 2024-08-02 | New | Pharmaceuticals | $2,296,880 | $2,296,880 | 06b |
| 2024-06-11 | New | Pharmaceuticals | $2,077,409 | $2,077,409 | 06b |
| 2021-02-22 | New | Pharmaceuticals | $4,276,000 | $4,276,000 | 06b |
| 2020-05-08 | New | Retailing | $2,500,000 | $2,399,500 | 06b |
Showing 1–5 of 5 filings